In response to the NIH Program Announcement PAR-13-279, Charles R. Drew University of Medicine and Science (CDU) proposes to continue and expand the success of the Accelerating excellence In Science (AXIS) program. AXIS is the integrated """"""""home"""""""" for clinical and translational research. AXIS houses experienced leadership as well as a myriad of clinical, translational, community-partnered activities, well matched by the education, training, and technology resources and excellent research core services. In the first five years, AXIS has laid the foundation at CDU to establish itself as the central hub of translational research. In the next five years, CDU will continue building on this progress and further develop its focus as the main research infrastructure program that will promote multi- and interdisciplinary collaborations between CDU investigators and community partners targeting health disparities. The vision of the University Research Enterprise is to be a leading player in the national effort to eliminate health disparities, specifically through AXIS in three areas of focus which disproportionally affect Service Planning Area 6: Cancer, Cardiometabolic Disease (CMD), and HIV/AIDS. AXIS proposes three programmatic goals that align with the vision of the University's Research Enterprise: """""""" Goal 1: To enhance the infrastructure capacity in translational research in the areas of Cancer, Cardiometabolic, and HIV/AIDS. Although other areas of research at CDU will also be served, the focus will be to create expertise and research success in these three areas.
This aim will also ensure that CDU continues to provide national leadership in reducing health disparities by increasing the quality and quantity of researchers from minority and underserved populations conducting disparities research. """"""""Goal 2: To integrate basic, clinical, and community-partnered translational research by fostering collaboration among disciplines, departments and schools at CDU, and collaboration with community leaders and investigators across other research institutions."""""""" Goal 3: To facilitate professional development and best practices in mentored clinical and translational research training on minority health and health disparities. """"""""To reach these goals, the AXIS Center will include 8 Cores that will offer services, resources, and training for all research conducted at CDU: 1 .Administrative Core, 2.Collaborations and Partnerships, and Community Core, 3.Professional Development and Pilots Core, 4. Evaluation Core, 5.Biomedical Informatics Core, 6.Research Design and Biostatistics Core, 7.Clinical Research Resources and Facilities Core, 8. Technology and Laboratory Core.

Public Health Relevance

Development of a robust infrastructure for clinical and translational research to address high priority disease areas of cancer, cardiometabolic disorders, and HIV/AIDs will significantly impact health disparities among underserved and ethnic/racial minority populations.

Agency
National Institute of Health (NIH)
Institute
National Institute on Minority Health and Health Disparities (NIMHD)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
2U54MD007598-06
Application #
8807130
Study Section
Special Emphasis Panel (ZMD1-RN (03))
Program Officer
Mcclure, Shelia A
Project Start
2009-09-28
Project End
2019-04-30
Budget Start
2014-07-10
Budget End
2015-04-30
Support Year
6
Fiscal Year
2014
Total Cost
$2,714,715
Indirect Cost
$919,945
Name
Charles R. Drew University of Medicine & Science
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
785877408
City
Los Angeles
State
CA
Country
United States
Zip Code
90059
Zhou, Yiming; Castonguay, Philip; Sidhom, Eriene-Heidi et al. (2017) A small-molecule inhibitor of TRPC5 ion channels suppresses progressive kidney disease in animal models. Science 358:1332-1336
Paz, Sylvia H; Jones, Loretta; Calderón, José L et al. (2017) Readability and Comprehension of the Geriatric Depression Scale and PROMIS(®) Physical Function Items in Older African Americans and Latinos. Patient 10:117-131
Bhat, Kruttika; Sarkissyan, Marianna; Wu, Yanyuan et al. (2017) GRO? overexpression drives cell migration and invasion in triple negative breast cancer cells. Oncol Rep 38:21-30
Bazargan-Hejazi, Shahrzad; Teruya, Stacey; Pan, Deyu et al. (2017) The theory of planned behavior (TPB) and texting while driving behavior in college students. Traffic Inj Prev 18:56-62
Tang, Kechun; Pasqua, Teresa; Biswas, Angshuman et al. (2017) Muscle injury, impaired muscle function and insulin resistance in Chromogranin A-knockout mice. J Endocrinol 232:137-153
Wu, Yong; Yu, Xiaoting; Yi, Xianghua et al. (2017) Aberrant Phosphorylation of SMAD4 Thr277-Mediated USP9x-SMAD4 Interaction by Free Fatty Acids Promotes Breast Cancer Metastasis. Cancer Res 77:1383-1394
Bazargan-Hejazi, Shahrzad; Arroyo, Jeffrey S; Hsia, Stanley et al. (2017) A Racial Comparison of Differences between Self-Reported and Objectively Measured Physical Activity among US Adults with Diabetes. Ethn Dis 27:403-410
Wu, Yanyuan; Sarkissyan, Marianna; Clayton, Sheilah et al. (2017) Association of Vitamin D3 Level with Breast Cancer Risk and Prognosis in African-American and Hispanic Women. Cancers (Basel) 9:
Chung, Seyung S; Adekoya, Debbie; Enenmoh, Ikechukwu et al. (2017) Salinomycin Abolished STAT3 and STAT1 Interactions and Reduced Telomerase Activity in Colorectal Cancer Cells. Anticancer Res 37:445-453
Wu, Y; Vadgama, J V (2017) Androgen Receptor as a Potential Target for Treatment of Breast Cancer. Int J Cancer Res Mol Mech 3:

Showing the most recent 10 out of 170 publications